Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000508

Drug Information
NameCP-945598
SynonymsOtenabant hydrochloride (USAN); CP 945598; otenabant; CHEMBL562668; D09363; 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-ethylamino-piperidine-4-carboxamide; CP-945,598; Otenabant (USAN/INN); 919516-56-6; 686347-12-6; 1-(8-(2-Chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide monohydrochloride; D09362; Otenabant hydrochloride; CP-945598; CID10052040; 686344-29-6
CompanyPfizer
IndicationObesity
[ICD9: 278   ICD10: E66]
Discontinued in Phase III    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C25H25Cl2N7O.ClH/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-2
3(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)2
7;/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35);1H
InChIKeyKPYUQCJBZGQHPL-UHFFFAOYSA-N
Canonical SMILESCCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl    
CAS NumberCAS 677010-34-3
FormulaC25H26Cl3N7O
PubChem Compound IDCID 16223963.
PubChem Substance IDSID 24906440.
TargetCannabinoid receptor 1Antagonist[2]
Ref 1Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. To Reference
Ref 2Pfizer. Product Development Pipeline. March 31 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543